New COVID-19 vaccine from HIPRA Human Health approved by MHRA

Bimervax, the COVID-19 vaccine developed by HIPRA Human Health, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

Combating Pharmaceutical Crime with On-Dose Authentication – Pharmaceutical Technology

Despite the best efforts of pharmaceutical manufacturers and regulators to improve the security and traceability of drug products, counterfeits continue to proliferate and cause considerable

September 4, 2024

In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see

Last year, just a few months after the Supreme Court’s reversal of Roe v. Wade ended the constitutional right to abortion in the United States,

June 23, 2023

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

Canadian researchers develop a cell-free DNA-based multimodal assay for early cancer detection in patients with Li-Fraumeni Syndrome, a high-cancer-risk condition. The assay outperforms conventional methods,

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.